Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Author(s) -
Julie A. Stading,
Jamie Herrmann,
Ryan W. Walters,
Christopher J. Destache,
Alan Chock
Publication year - 2009
Publication title -
diabetes spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.716
H-Index - 31
eISSN - 1944-7353
pISSN - 1040-9165
DOI - 10.2337/diaspect.22.4.241
Subject(s) - medicine , diabetes mellitus , pharmacist , ambulatory , stroke (engine) , type 2 diabetes , pharmacy , ambulatory care , disease , emergency medicine , health care , intensive care medicine , family medicine , mechanical engineering , economic growth , engineering , economics , endocrinology
change in A1C over a 2-year period in an outpatient clinic at a Veterans Administration institution. Diabetes care for the treatment group included the pharmacist, dietitian, and primary care provider (Team), with patients managed by the primary care provider and dietitian serv - ing as controls (Control). For Team patients, a clinical pharmacist met with patients every 3 months or as needed to help meet ADA goals for therapy. 8 This retrospective medical record
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom